The World Health Organization has resumed hydrochloroquine trial for treatment of COVID-19 virus.
This move is in line with the quest to proffer a lasting solution to the virus still ravaging the world.
The trail of hydrochloroquine will continue despite its ineffectiveness on the treatment of COVID-19 sampled among 96,032 patients as published by The Lancet, a medical journal.
Recall, Tedros Ghebreyesus the WHO director-general while citing the Lancet study, announced a temporary pause in the WHO solidarity trial of the drug three days after the publication.
In a turn of events, Tedros during a virtual press conference on Wednesday said the drug trial will resume so as to find a permanent solution to the virus.
Also, Tedros noted that after reviewing available data on the drug by the WHO data safety monitoring board , findings revealed that there was no reason to discontinue the trial.
“Last week, the executive group of the Solidarity Trial decided to implement a temporary pause of the hydroxychloroquine arm of the trial, because of concerns raised about the safety of the drug,” he said.
“This decision was taken as a precaution while the safety data were reviewed. The data safety and monitoring committee of the solidarity trial has been reviewing the data.
“On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.
“The executive group received this recommendation and endorsed continuation of all arms of the solidarity trial, including hydroxychloroquine. The executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm of the trial.
“The data safety and monitoring committee will continue to closely monitor the safety of all therapeutics being tested in the solidarity trial.” He said.
Based on available data, the #COVID19 Solidarity Trial Data Safety & Monitoring Committee recommended there are no reasons to modify the trial protocol. The Executive Group endorsed the continuation of all arms of the Trial, including the use of hydroxychloroquine. https://t.co/r88DVEvZ3j pic.twitter.com/cYITShxcE7
— Tedros Adhanom Ghebreyesus (@DrTedros) June 3, 2020